(Q36468744)

14 August 2017

Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer (English)

1 reference

14 August 2017

1 reference

9

Fred Saad

1 reference

14 August 2017

Kanishka Sircar

1

1 reference

14 August 2017

Heng Huang

2

1 reference

14 August 2017

Limei Hu

3

1 reference

14 August 2017

David Cogdell

4

1 reference

14 August 2017

Jasreman Dhillon

5

1 reference

14 August 2017

Vassiliki Tzelepi

6

1 reference

14 August 2017

Eleni Efstathiou

7

1 reference

14 August 2017

Ismaël H Koumakpayi

8

1 reference

14 August 2017

Dijun Luo

10

1 reference

14 August 2017

Tarek A Bismar

11

1 reference

14 August 2017

Ana Aparicio

12

1 reference

14 August 2017

Patricia Troncoso

13

1 reference

14 August 2017

Nora Navone

14

1 reference

14 August 2017

Wei Zhang

15

1 reference

14 August 2017

language of work or name

English

0 references

publication date

11 January 2012

1 reference

The American Journal of Pathology

14 August 2017

1 reference

14 August 2017

180

1 reference

14 August 2017

3

1 reference

14 August 2017

895-903

1 reference

Implication of platelet-derived growth factor receptor alpha in prostate cancer skeletal metastasis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

30 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Integrative genomic profiling of human prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Stationary wavelet packet transform and dependent laplacian bivariate shrinkage estimator for array-CGH data smoothing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

CYP17 inhibition as a hormonal strategy for prostate cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Integrative analysis of genomic aberrations associated with prostate cancer progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Asparagine synthetase chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Mechanistic issues in asparagine synthetase catalysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Trisomy 7: a potential cytogenetic marker of human prostate cancer progression

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4715215

Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization

4 December 2018

1 reference

12 December 2020

p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma

1 reference

12 December 2020

Inactivation of the p53 pathway in prostate cancer: impact on tumor progression

1 reference

12 December 2020

Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray

1 reference

12 December 2020

Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma

1 reference

12 December 2020

10.1016/J.AJPATH.2011.11.030

Identifiers

DOI

1 reference

release_ycqrhpt2xzfgfee3qjoeelvpcy

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ycqrhpt2xzfgfee3qjoeelvpcy

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

PubMed publication ID

22245216

1 reference